Medicinal preparations containing antigens or antibodies (materials for immunoassay G 01 N 33/53) [2]
Notes
(1)
Groups A 61 K 39/002 to A 61 K 39/295 cover preparations containing protozoa, bacteria, viruses, or subunits thereof, e.g. membrane parts. [3]
(2)
Preparation of antigen or antibody compositions is also classified in subclass C 12 N, if the step of cultivating the micro-organism is of interest. [3]
39
/
002
•
Protozoa antigens [3]
39
/
005
•
•
Trypanosoma antigens [3]
39
/
008
•
•
Leishmania antigens [3]
39
/
012
•
•
Coccidia antigens [3]
39
/
015
•
•
Hemosporidia antigens, e.g. Plasmodium antigens [3]
39
/
018
•
•
•
Babesia antigens, e.g. Theileria antigens [3]
39
/
02
•
Bacterial antigens [2]
39
/
04
•
•
Mycobacterium, e.g. Mycobacterium tuberculosis [2,3]
39
/
05
•
•
Corynebacterium; Propionibacterium [3]
39
/
07
•
•
Bacillus [3]
39
/
08
•
•
Clostridium, e.g. Clostridium tetani [2]
39
/
085
•
•
Staphylococcus [3]
39
/
09
•
•
Streptococcus [3]
39
/
095
•
•
Neisseria [3]
39
/
10
•
•
Brucella; Bordetella, e.g. Bordetella pertussis [2,3]
39
/
102
•
•
Pasteurella; Haemophilus [3]
39
/
104
•
•
Pseudomonas [3]
39
/
106
•
•
Vibrio; Campylobacter [3]
39
/
108
•
•
Escherichia; Klebsiella [3]
39
/
112
•
•
Salmonella; Shigella [3]
39
/
114
•
•
Fusobacterium [3]
39
/
116
•
•
Polyvalent bacterial antigens [3]
39
/
118
•
Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci [3]
39
/
12
•
Viral antigens [2]
39
/
125
•
•
Picornaviridae, e.g. calicivirus [3]
39
/
13
•
•
•
Poliovirus [3]
39
/
135
•
•
•
Foot-and-mouth disease virus [3]
39
/
145
•
•
Orthomyxoviridae, e.g. influenza virus [3]
39
/
15
•
•
Reoviridae, e.g. calf diarrhea virus [3]
39
/
155
•
•
Paramyxoviridae, e.g. parainfluenza virus [3]
39
/
165
•
•
•
Mumps or measles virus [3]
39
/
17
•
•
•
Newcastle disease virus [3]
39
/
175
•
•
•
Canine distemper virus [3]
39
/
187
•
•
Hog cholera virus [3]
39
/
193
•
•
Equine encephalomyelitis virus [3]
39
/
20
•
•
Rubella virus [2]
39
/
205
•
•
Rhabdoviridae, e.g. rabies virus [3]
39
/
21
•
•
Retroviridae, e.g. equine infectious anemia virus [3]
39
/
215
•
•
Coronaviridae, e.g. avian infectious bronchitis virus [3]
39
/
225
•
•
•
Porcine transmissible gastroenteritis virus [3]
39
/
23
•
•
Parvoviridae, e.g. feline panleukopenia virus [3]
39
/
235
•
•
Adenoviridae [3]
39
/
245
•
•
Herpetoviridae, e.g. herpes simplex virus [3]
39
/
25
•
•
•
Varicella-zoster virus [3]
39
/
255
•
•
•
Marek's disease virus [3]
39
/
265
•
•
•
Infectious rhinotracheitis virus [3]
39
/
27
•
•
•
Equine rhinopneumonitis virus [3]
39
/
275
•
•
Poxviridae, e.g. avipoxvirus [3]
39
/
285
•
•
•
Vaccinia virus or variola virus [3]
39
/
29
•
•
Hepatitis virus [3]
39
/
295
•
•
Polyvalent viral antigens (vaccinia virus or variola virus A 61 K 39/285); Mixtures of viral and bacterial antigens [3]
39
/
35
•
Allergens [3]
39
/
36
•
•
from pollen [2,3]
39
/
38
•
Antigens from snakes [2]
39
/
385
•
Haptens or antigens, bound to carriers [3]
39
/
39
•
characterised by the immunostimulating additives, e.g. chemical adjuvants [3]
39
/
395
•
Antibodies (agglutinins A 61 K 38/36); Immunoglobulins; Immune serum, e.g. antilymphocytic serum [3]